Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Ferris

Showing results (321-330 of 818) with videos related to

Pageof 82
Sort By:
Cell|March 5, 2013
H3K4me3 interactions with TAF3 regulate preinitiation complex assembly and selective gene activationShannon M Lauberth, Takahiro Nakayama, Xiaolin Wu, et al.
International Journal of Molecular Sciences|March 17, 2017
TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of ActionWenwen Du, Min Yang, Abbey Turner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2002
Alterations in the frequency of dendritic cell subsets in the peripheral circulation of patients with squamous cell carcinomas of the head and neckThomas K Hoffmann, Jan Müller-Berghaus, Robert L Ferris, et al.
JAMA Ophthalmology|July 22, 2016
Evaluating the Validity of the Age-Related Eye Disease Study Grading Scale for Age-Related Macular Degeneration: AREDS2 Report 10Susan Vitale, Traci E Clemons, Elvira Agrón, et al.
Clinical Immunology (Orlando, Fla.)|June 1, 2005
Recent thymic emigrants and subsets of naive and memory T cells in the circulation of patients with head and neck cancerIris Kuss, Carsten Schaefer, Tony E Godfrey, et al.
Oncogene|July 12, 2005
Chemokine receptor 7 activates phosphoinositide-3 kinase-mediated invasive and prosurvival pathways in head and neck cancer cells independent of EGFRJun Wang, Xin Zhang, Sufi M Thomas, et al.
JAMA Otolaryngology-- Head & Neck Surgery|March 5, 2016
A 20-Year Review of 75 Cases of Salivary Duct CarcinomaMark R Gilbert, Arun Sharma, Nicole C Schmitt, et al.
Carcinogenesis|March 20, 2016
Innate immune signaling through differential RIPK1 expression promote tumor progression in head and neck squamous cell carcinomaKevin D McCormick, Arundhati Ghosh, Sumita Trivedi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2016
CD137 Stimulation Enhances Cetuximab-Induced Natural Killer: Dendritic Cell Priming of Antitumor T-Cell Immunity in Patients with Head and Neck CancerRaghvendra M Srivastava, Sumita Trivedi, Fernando Concha-Benavente, et al.
Cancer Treatment Reviews|January 14, 2023
Inhibiting the inhibitors: Development of the IAP inhibitor xevinapant for the treatment of locally advanced squamous cell carcinoma of the head and neckRobert L Ferris, Kevin Harrington, Jonathan D Schoenfeld, et al.
Pageof 82

Showing results (321-330 of 818) with videos related to

Sort By:
Pageof 82
Cell|March 5, 2013
H3K4me3 interactions with TAF3 regulate preinitiation complex assembly and selective gene activationShannon M Lauberth, Takahiro Nakayama, Xiaolin Wu, et al.
International Journal of Molecular Sciences|March 17, 2017
TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of ActionWenwen Du, Min Yang, Abbey Turner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2002
Alterations in the frequency of dendritic cell subsets in the peripheral circulation of patients with squamous cell carcinomas of the head and neckThomas K Hoffmann, Jan Müller-Berghaus, Robert L Ferris, et al.
JAMA Ophthalmology|July 22, 2016
Evaluating the Validity of the Age-Related Eye Disease Study Grading Scale for Age-Related Macular Degeneration: AREDS2 Report 10Susan Vitale, Traci E Clemons, Elvira Agrón, et al.
Clinical Immunology (Orlando, Fla.)|June 1, 2005
Recent thymic emigrants and subsets of naive and memory T cells in the circulation of patients with head and neck cancerIris Kuss, Carsten Schaefer, Tony E Godfrey, et al.
Oncogene|July 12, 2005
Chemokine receptor 7 activates phosphoinositide-3 kinase-mediated invasive and prosurvival pathways in head and neck cancer cells independent of EGFRJun Wang, Xin Zhang, Sufi M Thomas, et al.
JAMA Otolaryngology-- Head & Neck Surgery|March 5, 2016
A 20-Year Review of 75 Cases of Salivary Duct CarcinomaMark R Gilbert, Arun Sharma, Nicole C Schmitt, et al.
Carcinogenesis|March 20, 2016
Innate immune signaling through differential RIPK1 expression promote tumor progression in head and neck squamous cell carcinomaKevin D McCormick, Arundhati Ghosh, Sumita Trivedi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2016
CD137 Stimulation Enhances Cetuximab-Induced Natural Killer: Dendritic Cell Priming of Antitumor T-Cell Immunity in Patients with Head and Neck CancerRaghvendra M Srivastava, Sumita Trivedi, Fernando Concha-Benavente, et al.
Cancer Treatment Reviews|January 14, 2023
Inhibiting the inhibitors: Development of the IAP inhibitor xevinapant for the treatment of locally advanced squamous cell carcinoma of the head and neckRobert L Ferris, Kevin Harrington, Jonathan D Schoenfeld, et al.
Pageof 82